scholarly journals O IMPACTO DO USO DE SUBSTÂNCIAS PSICOATIVAS E SUAS REPERCUSSÕES NA CAVIDADE BUCAL: REVISÃO INTEGRATIVA

2021 ◽  
Vol 7 (2) ◽  
pp. 239-252
Author(s):  
Maria Helena Lira Farias Teotônio ◽  
Vitória Da Silva Lima ◽  
Kauana Da Silva Andrade ◽  
Bianca Maria de Melo Costa ◽  
Maria Cristina Tavares de Medeiros Honorato
Keyword(s):  
Substance Related Disorders

RESUMO Introdução: O consumo de drogas pode promover consequências para o organismo, sobretudo a cavidade bucal.  Objetivo: Verificar quais são as substâncias psicoativas mais utilizadas e suas repercussões na cavidade bucal.  Metodologia: Foi realizada uma revisão de literatura na base de dados Medical Publications (PubMed) com os descritores “Transtornos Relacionados ao Uso de Substâncias (Substance-Related Disorders)” e “Odontologia (Dentistry)” com o operador booleano “And”. Resultados: A amostra foi composta por 5 artigos selecionados, onde a maconha, cocaína e o crack foram as substâncias psicoativas mais utilizadas pelos usuários de drogas, sendo a perda dentária, presença de cárie dentária e doença periodontal as principais repercussões bucais. Conclusões: O consumo de substâncias psicoativas aumenta o limiar de dor, podendo mascarar a sintomatologia dolorosa das manifestações bucais e postergar a busca por tratamento odontológico, agravando, por vezes, a condição bucal do indíviduo. Sendo portanto, de extrema importância o conhecimento e atuação do cirurgião dentista frente ao usuário de drogas, desde a prevenção, diagnóstico e tratamento do caso. Palavras-Chave: Transtornos relacionados ao uso de substâncias; Odontologia, Manifestações bucais.

Affective, anxiety, and substance-related disorders in patients undergoing herniated disc surgery

2010 ◽  
Vol 46 (11) ◽  
pp. 1181-1190 ◽  
Author(s):  
Margrit Zieger ◽  
Melanie Luppa ◽  
Herbert Matschinger ◽  
Hans J. Meisel ◽  
Lutz Günther ◽  
...  
Keyword(s):  
Herniated Disc ◽  
Disc Surgery ◽  
Substance Related Disorders

Sharing Psychiatric Care with Primary Care Physicians: The Toronto Doctors Hospital Experience (1991–1995)

1997 ◽  
Vol 42 (9) ◽  
pp. 950-954 ◽  
Author(s):  
Ty Turner ◽  
Alicia de Sorkin
Keyword(s):  
Primary Care Physicians ◽  
Care Program ◽  
Shared Care ◽  
Care Experience ◽  
Hospital Experience ◽  
Large Numbers ◽  
Diagnostic Characteristics ◽  
Multiplier Effect ◽  
Care Approach ◽  
Substance Related Disorders

Objectives: To investigate the shared mental health care experience of the psychiatry department of a small urban general hospital, which serves an ethnoculturally diverse population. Methods: A chart survey was undertaken of all patients referred by community physicians to a new shared care program between January 1991 and December 1995. Selected demographic and diagnostic characteristics were collected and analyzed. Results: Seven hundred and thirteen patients were assessed. They were principally female, ethnoculturally varied, and highly comorbid. The most striking association involved mood and substance-related disorders. Conclusion: The Doctors Hospital experience shows that the shared care approach can reach large numbers of patients through a multiplier effect. Additionally, this approach has the potential to enhance access for ethnoculturally varied and diagnostically complex groups.

scholarly journals Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany

2021 ◽  
Vol 12 ◽  
Author(s):  
Norbert Scherbaum ◽  
Udo Bonnet ◽  
Henning Hafermann ◽  
Fabrizio Schifano ◽  
Stefan Bender ◽  
...  
Keyword(s):  
Drug Consumption ◽  
Illegal Drugs ◽  
Novel Psychoactive Substances ◽  
Psychoactive Substances ◽  
Addiction Services ◽  
Public Areas ◽  
Single Subjects ◽  
Western Germany ◽  
Low Threshold ◽  
Substance Related Disorders

Background: In response to the COVID-19-pandemic, a lockdown was established in the middle of March 2020 by the German Federal Government resulting in drastic reduction of private and professional traveling in and out of Germany with a reduction of social contacts in public areas.Research Questions: We seek evidence on whether the lockdown has led to a reduced availability of illegal drugs and whether subjects with substance-related problems tried to cope with possible drug availability issues by increasingly obtaining drugs via the internet, replacing their preferred illegal drug with novel psychoactive substances, including new synthetic opioids (NSO), and/or by seeking drug treatment.Methods: A questionnaire was anonymously filled in by subjects with substance-related disorders, typically attending low-threshold settings, drug consumption facilities, and inpatient detoxification wards from a range of locations in the Western part of Germany. Participants had to both identify their main drug of abuse and to answer questions regarding its availability, price, quality, and routes of acquisition.Results: Data were obtained from 362 participants. The most frequent main substances of abuse were cannabis (n = 109), heroin (n = 103), and cocaine (n = 75). A minority of participants reported decreased availability (8.4%), increased price (14.4%), or decreased quality (28.3%) of their main drug. About 81% reported no change in their drug consumption due to the COVID-19 pandemic and the lockdown. A shift to the use of novel psychoactive substances including NSO were reported only by single subjects. Only 1–2% of the participants obtained their main drug via the web.Discussion: Present findings may suggest that recent pandemic-related imposed restrictions may have not been able to substantially influence either acquisition or consumption of drugs within the context of polydrug users (including opiates) attending a range of addiction services in Germany.

Comorbidity between mood and substance-related disorders: A systematic review and meta-analysis

2021 ◽  
pp. 000486742110547
Author(s):  
Sukanta Saha ◽  
Carmen CW Lim ◽  
Louisa Degenhardt ◽  
Danielle L Cannon ◽  
Monique Bremner ◽  
...  
Keyword(s):  
Mood Disorders ◽  
Drug Dependence ◽  
Odds Ratio ◽  
Meta Analysis ◽  
Geographical Location ◽  
Dysthymic Disorder ◽  
Increased Risk ◽  
Meta Analyses ◽  
Substance Related Disorders ◽  
Study Designs

Background and Objectives: Evidence indicates that mood disorders often co-occur with substance-related disorders. However, pooling comorbidity estimates can be challenging due to heterogeneity in diagnostic criteria and in the overall study design. The aim of this study was to systematically review and, where appropriate, meta-analyse estimates related to the pairwise comorbidity between mood disorders and substance-related disorders, after sorting these estimates by various study designs. Methods: We searched PubMed (MEDLINE), Embase, CINAHL and Web of Science for publications between 1980 and 2017 regardless of geographical location and language. We meta-analysed estimates from original articles in 4 broadly defined mood and 35 substance-related disorders. Results: After multiple eligibility steps, we included 120 studies for quantitative analysis. In general, regardless of variations in diagnosis type, temporal order or use of adjustments, there was substantial comorbidity between mood and substance-related disorders. We found a sixfold elevated risk between broadly defined mood disorder and drug dependence (odds ratio = 5.7) and fivefold risk between depression and cannabis dependence (odds ratio = 4.9) while the highest pooled estimate, based on period prevalence risk, was found between broadly defined dysthymic disorder and drug dependence (odds ratio = 11.3). Based on 56 separate meta-analyses, all pooled odds ratios were above 1, and 46 were significantly greater than 1 (i.e. the 95% confidence intervals did not include 1). Conclusion: This review found robust and consistent evidence of an increased risk of comorbidity between many combinations of mood and substance-related disorders. We also identified a number of under-researched mood and substance-related disorders, suitable for future scrutiny. This review reinforces the need for clinicians to remain vigilant in order to promptly identify and treat these common types of comorbidity.

Substance-related disorders and sleep

2021 ◽  
Author(s):  
Anthony N. Reffi ◽  
Bhanu Prakash Kolla ◽  
Mandilyn Graham ◽  
M. Elizabeth Cardoni ◽  
Sajni Amin ◽  
...  
Keyword(s):  
Substance Related Disorders
Sign in / Sign up

Export Citation Format

Share Document